During the past decade, Tokyo Medical University Hachioji Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Medical University Hachioji Medical Center" #1 collaborator was "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Medical University Hachioji Medical Center" are "Acute Kidney Injury Due to Sepsis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Tokyo Medical University Hachioji Medical Center" in a lesser frequency.

Most popular intervention types in "Tokyo Medical University Hachioji Medical Center" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (1 trials), "Placebo" (1 trials), "Placebo to match filgotinib" (1 trials) and "Recombinant human alkaline phosphatase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Medical University Hachioji Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Medical University Hachioji Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tokyo Medical University Hachioji Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Medical University Hachioji Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".